Celltrion Financial Statements From 2010 to 2024

068270 Stock   194,400  500.00  0.26%   
Celltrion financial statements provide useful quarterly and yearly information to potential Celltrion investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Celltrion financial statements helps investors assess Celltrion's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Celltrion's valuation are summarized below:
Celltrion does not presently have any fundamental signals for analysis.
Check Celltrion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celltrion's main balance sheet or income statement drivers, such as , as well as many indicators such as . Celltrion financial statements analysis is a perfect complement when working with Celltrion Valuation or Volatility modules.
  
This module can also supplement various Celltrion Technical models . Check out the analysis of Celltrion Correlation against competitors.

Celltrion Company Debt To Equity Analysis

Celltrion's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

D/E

 = 

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis

Current Celltrion Debt To Equity

    
  0.32 %  
Most of Celltrion's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celltrion is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Competition

According to the company disclosure, Celltrion has a Debt To Equity of 0.32%. This is 99.4% lower than that of the Healthcare sector and 99.7% lower than that of the Pharmaceuticals And Biosciences industry. The debt to equity for all Republic of Korea stocks is 99.34% higher than that of the company.

Celltrion Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Celltrion's current stock value. Our valuation model uses many indicators to compare Celltrion value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Celltrion competition to find correlations between indicators driving Celltrion's intrinsic value. More Info.
Celltrion is number one stock in price to earning category among its peers. It also is number one stock in net income category among its peers making up about  3,112,651,646  of Net Income per Price To Earning. Comparative valuation analysis is a catch-all model that can be used if you cannot value Celltrion by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Celltrion's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Celltrion Financial Statements

Celltrion stakeholders use historical fundamental indicators, such as Celltrion's revenue or net income, to determine how well the company is positioned to perform in the future. Although Celltrion investors may analyze each financial statement separately, they are all interrelated. For example, changes in Celltrion's assets and liabilities are reflected in the revenues and expenses on Celltrion's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Celltrion. Please read more on our technical analysis and fundamental analysis pages.
Celltrion, Inc. researches, develops, manufactures, and sells biopharmaceutical solutions in South Korea and internationally.

Pair Trading with Celltrion

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Celltrion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celltrion will appreciate offsetting losses from the drop in the long position's value.

Moving together with Celltrion Stock

  0.7005380 Hyundai MotorPairCorr
  0.65005385 Hyundai MotorPairCorr

Moving against Celltrion Stock

  0.55041510 SM EntertainmentPairCorr
  0.43105560 KB Financial GroupPairCorr
  0.42032830 Samsung LifePairCorr
  0.33316140 Woori Financial GroupPairCorr
The ability to find closely correlated positions to Celltrion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Celltrion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Celltrion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Celltrion to buy it.
The correlation of Celltrion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Celltrion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Celltrion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Celltrion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Celltrion Stock

Celltrion financial ratios help investors to determine whether Celltrion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Celltrion with respect to the benefits of owning Celltrion security.